Abstract:Background: The osteogenic capabilities and biodegradability of octacalcium phosphate (OCP) composites make them unique. Despite the excellent characteristics of OCP, their use is limited due to handling difficulties. In this study, we aimed to evaluate and compare three types of OCPs (cemented OCP (C-OCP), C-OCP with collagen (OCP/Col), and synthetic OCP (S-OCP) with alginate (OCP/Alg)) versus commercially available β-tricalcium phosphate (β-TCP) regarding their potential to accelerate bone formation in defective rat tibias. Methods: The specimens with OCP composite were manufactured into 5 mm cubes and inserted into the segmental defects of rat tibias fixed with an external fixator. In addition, 3 mm-hole defects in rat tibias were evaluated to compare the graft material properties in different clinical situations. Serial X-ray studies were evaluated weekly and the tibias were harvested at postoperative 6 weeks or 8 weeks for radiologic evaluation. Histological and histomorphometric analyses were performed to evaluate the acceleration of bone formation. Results: In the critical-defect model, OCP/Alg showed bone bridges between segmentally resected bone ends that were comparable to those of β-TCP. However, differences were observed in the residual graft materials. Most β-TCP was maintained until 8 weeks postoperatively; however, OCP/Alg was more biodegradable. In addition calcification in the β-TCP occurred at the directly contacted area between graft particles and bony ingrowth was observed in the region adjacent resected surface of tibia. In contrast, no direct bony ingrowth was observed in OCP-based materials, but osteogenesis induced from resected surface of tibia was more active. In the hole-defect model, OCP/Col accelerated bone formation. β-TCP and OCP/Alg showed similar patterns with relatively higher biodegradability. In histology, among the OCP-based materials, directly contacted new bone was formed only in OCP/Alg group. The new bone formation in the periphery area of graft materials was much more active in the OCP-based materials, and the newly formed bone showed a thicker trabecular and more mature appearance than the β-TCP group. Conclusions: In this study, OCP/Alg was equivalent to β-TCP in the acceleration of bone formation with better biodegradability appropriate for clinical situations in different circumstances. Our OCP/Col composite showed fast degradation, which makes it unsuitable for use in mechanical stress conditions in clinical orthopedic settings. The translational potential of this article: In our research, we compared our various manufactured OCP composites to commercially available β-TCP in critical-defect rat tibia model. OCP/Col showed acceleration in hole-defect model as previous studies in dental field but in our critical-sized defect model it resorbed fast without acceleration of bony union. OCP/Alg showed matched results compared to β-TCP and relatively fast resorption so we showed market value in special clinical indication depending on treatment strategy. This is the first OCP composite study in orthopaedics with animal critical-sized tibia bone study and further study should be considered for clinical application based on this study.

A composite of polymethylmethacrylate, hydroxyapatite, and β-tricalcium phosphate for bone regeneration in an osteoporotic rat model

Bioactive poly (methyl methacrylate) bone cement for the treatment of osteoporotic vertebral compression fractures

Bioactive Mineralized Small Intestinal Submucosa Acellular Matrix/pmma Bone Cement for Vertebral Bone Regeneration.

Improved Bone Ingrowth of Tricalcium Phosphate Filled Poly(methyl Methacrylate) (PMMA) Bone Cements in Vivo

A bioactive polymethylmethacrylate bone cement for prosthesis fixation in osteoporotic hip replacement surgery

Composite cement embedded in a biopolymer matrix for bone tissue regeneration

Healing potentials of polymethylmethacrylate bone cement combined with platelet gel in the critical-sized radial bone defect of rats

In Vitro Apatite Mineralization, Degradability, Cytocompatibility and in Vivo New Bone Formation and Vascularization of Bioactive Scaffold of Polybutylene Succinate/Magnesium Phosphate/Wheat Protein Ternary Composite

In vivo evaluation of hyaluronic acid–polyethylene glycol amended PMMA bone cement for orthopaedic application

Degradation of bone repairing composite of calcium polyphosphate fiber, calcium phospate cement and micromorselized bone in vitro

Injectable and Biodegradable Composite Bone Filler Composed of Poly(propylene Fumarate) and Calcium Phosphate Ceramic for Vertebral Augmentation Procedure: an in Vivo Porcine Study.

Injectable bioactive polymethyl methacrylate–hydrogel hybrid bone cement loaded with BMP-2 to improve osteogenesis for percutaneous vertebroplasty and kyphoplasty

Poly (propylene Fumarate)/β-Calcium Phosphate Composites for Enhanced Bone Repair.

Pharmacological Studies on the Composite of CPC/rhBMP-2 Improving the Fracture Healing of Osteoporotic Rats

Bioactive composite hydrogel with effects of robust promoting osteogenesis and immunomodulation for osteoporotic bone regeneration

Quaternised Chitosan-Loaded Polymethylmethacrylate Bone Cement: Biomechanical and Histological Evaluations

Acceleration of bone formation by octacalcium phosphate composite in a rat tibia critical-sized defect

A Composite Lactide-Mineral 3D-Printed Scaffold for Bone Repair and Regeneration

Osteogenesis and Degradation Behavior of Rhbmp-2／Β-tricalcium Phosphate Porous Composite Materials

Evaluation of Biocomposite Cements for Bone Defect Repair in Rat Models

In vitro studies of composite bone filler based on poly(propylene fumarate) and biphasic α-tricalcium phosphate/hydroxyapatite ceramic powder.